Turning over a new leaf—pharmacologic therapy in obstructive sleep apnea

J Hedner, D Zou - Sleep Medicine Clinics, 2022 - sleep.theclinics.com
Obstructive sleep apnea (OSA) is a common condition that has turned out to provide a
challenge for physicians and the health-care systems. 1 This particular form of sleep …

[HTML][HTML] Obstructive sleep apnea: A review for the orthodontist

JM Palomo, VD Piccoli, LM MENEZES - Dental Press Journal of …, 2023 - SciELO Brasil
Introduction: Obstructive sleep apnea (OSA) affects an important part of the population and
is characterized by recurrent total or partial obstruction of the upper airway (UA) during …

[HTML][HTML] Perspective: Systematic review and meta-analysis in obstructive sleep apnea–What is lacking?

D Lisik, GN Pires, D Zou - Sleep Medicine, 2023 - Elsevier
Obstructive sleep apnea (OSA) affects nearly one billion of the global adult population. It is
associated with substantial burden in terms of quality of life, cognitive function, and …

Sleep apnea endotypes: from the physiological laboratory to scalable polysomnographic measures

E Finnsson, E Arnardóttir, WJ Cheng, RM Alex… - Frontiers in …, 2023 - frontiersin.org
Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent upper
airway obstruction during sleep. Despite the availability of continuous positive airway …

Impact of a weight-loss rehabilitation program on sleep apnea risk and subjective sleepiness in patients with overweight/obesity: The Dietsleep study

S Bailly, O Fabre, M Cals-Maurette, L Pantagis… - Journal of Clinical …, 2022 - mdpi.com
Obstructive sleep apnea (OSA) is one of the most frequent chronic diseases, and comorbid
obesity occurs in more than 60% of cases. Variations in body weight influence both OSA …

Effects of mandibular advancement devices on upper airway dimensions in obstructive sleep apnea: responders versus non-responders

X Shi, F Lobbezoo, H Chen, BRAM Rosenmöller… - Clinical Oral …, 2023 - Springer
Study objectives To compare the effects of mandibular advancement device (MAD) therapy
on upper airway dimensions between responders and non-responders with mild to …

Domiciliary transcutaneous electrical stimulation in patients with obstructive sleep apnoea and limited adherence to continuous positive airway pressure therapy: a …

D Ratneswaran, M Cheng, E Nasser, R Madula… - …, 2023 - thelancet.com
Background Hypoglossal nerve stimulation (HNS) for obstructive sleep apnoea (OSA) is a
novel way to manage the condition. We hypothesised that in patients with OSA and limited …

CPAP resumption after a first termination and impact on all-cause mortality in France

JL Pépin, R Tamisier, AV Benjafield… - European …, 2024 - Eur Respiratory Soc
Background Continuation of continuous positive airway pressure (CPAP) therapy after initial
prescription has been shown to reduce all-cause mortality versus therapy termination …

Non-CPAP therapy for obstructive sleep apnoea

J Verbraecken, M Dieltjens, SO de Beeck, A Vroegop… - Breathe, 2022 - Eur Respiratory Soc
Treatment of obstructive sleep apnoea in adults is evolving, from a “one treatment fits all” to
a more individualised approach. The spectrum of treatment options is broad and …

New pharmacologic agents for obstructive sleep apnoea: what do we know and what can we expect?

J Hedner, D Zou - Current Opinion in Pulmonary Medicine, 2022 - journals.lww.com
Recent insights into the pathophysiology of OSA have opened possibilities to develop
personalized therapy. Drugs addressing fundamental aspects of the sleep and breathing …